Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Cancer Research|June 14, 2012
BRAF inhibitor vemurafenib improves the antitumor activity of adoptive cell immunotherapyRichard C Koya, Stephen Mok, Nicholas Otte, et al.Journal for Immunotherapy of Cancer|October 5, 2021
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancerRavikumar Muthuswamy, Aj Robert McGray, Sebastiano Battaglia, et al.Plos One|September 22, 2010
Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanomaBegoña Comin-Anduix, Hooman Sazegar, Thinle Chodon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Effects of MAPK and PI3K pathways on PD-L1 expression in melanomaMohammad Atefi, Earl Avramis, Amanda Lassen, et al.Cancer Immunology Research|May 6, 2014
Exposure to a histone deacetylase inhibitor has detrimental effects on human lymphocyte viability and functionDeborah J L Wong, Amol Rao, Earl Avramis, et al.Nature Medicine|May 24, 2011
A clinical microchip for evaluation of single immune cells reveals high functional heterogeneity in phenotypically similar T cellsChao Ma, Rong Fan, Habib Ahmad, et al.Cancer Research|July 20, 2014
HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized miceEric H Gschweng, Melissa N McCracken, Michael L Kaufman, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 23, 2018
Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy ProductsTheodore S Nowicki, Helena Escuin-Ordinas, Earl Avramis, et al.Clinical Immunology (Orlando, Fla.)|June 16, 2010
MHC-I-restricted melanoma antigen specific TCR-engineered human CD4+ T cells exhibit multifunctional effector and helper responses, in vitroSwagatam Ray, Arvind Chhabra, Nitya G Chakraborty, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
CTLA4 blockade broadens the peripheral T-cell receptor repertoireLidia Robert, Jennifer Tsoi, Xiaoyan Wang, et al.Pageof 4